Epigallocatechin-3-Gallate Enhances the Therapeutic Effects of Leptomycin B on Human Lung Cancer A549 Cells

Our previous studies have shown Leptomycin B (LMB) is a promising antilung cancer drug. Epigallocatechin-3-gallate (EGCG) has antitumor properties but a debatable clinical application. The objective of this study is to evaluate the combination therapeutic effect of LMB and EGCG and its molecular mec...

Descripción completa

Detalles Bibliográficos
Autores principales: Cromie, Meghan M., Gao, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397486/
https://www.ncbi.nlm.nih.gov/pubmed/25922640
http://dx.doi.org/10.1155/2015/217304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397486/
https://www.ncbi.nlm.nih.gov/pubmed/25922640
http://dx.doi.org/10.1155/2015/217304

Ejemplares similares